Tag: Breast Cancer

PROteolysis TArgeting Chimeras (PROTACs) are heterobifunctional molecules consisting of two ligands. It contains an “anchor” binding to an E3 ubiquitin ...

89 out every 100 women diagnosed with invasive breast cancer now surviving five or more years beyond diagnosis. Tests to ...